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Tei Index and B-Type Natriuretic Peptide in Assessment of High-risk
Patients with Acute Coronary Artery Syndromes
GAO-XING ZHANG, XUE-FANG ZHANG, BIAO CHEN, ZHAO-XIN LAI, RU-MING LIN, YU-CHENG PENG,
WEI-DONG GAO, QIANG REN, JUN-XING LAI, AN-JIAN SONG, YAN-HUA SUN
From Jiangmen Central Hospital, Sun Yat-Sen University, Guangdong Province, Jiangmen 529030, China
ZHANG ET AL.: Tei Index and B-Type Natriuretic Peptide in Assessment of High-risk Patients with Acute Coronary
Artery Syndromes. In order to assess the value of Doppler echocardiographic Tei index and B-Type natriuretic
peptide (BNP) in evaluating high-risk patients with acute coronary artery syndromes and their relationship with
myocardial ischemia. Eighty-three consecutive patients and eighty controls were included, according to ACC/AHA
directions, patients were divided into low-risk group and high-risk group, all participants had undergone
echocardiography, neurohormonal analysis, coronary angiography, Gensini score were recorded. All data were
analyzed by SPSS 13.0 software. The results showed that tei index and BNP were higher in patients with acute
coronary artery syndromes (0.32±0.06, 0.48±0.09, 0.68±0.11, p<0.05; median 29.2, IQR 11.5-48.6, median 94.5,
IQR 39.1-168.2, median 458.8, IQR 183.8-1295.2, p<0.05), and the difference between low-risk group and high-risk
group was still significantly (0.48±0.09 vs. 0.68±0.11, p<0.05; median 94.5, IQR39.1-168.2 vs. median 458.8,
IQR183.8-1295.2, p<0.05). They were independent predictors of myocardial ischemia (r=0.52, p<0.01; r=0.32,
p<0.01), and were useful in assessing high-risk patients with acute coronary artery syndromes. (J HK Coll Cardiol
2009;17:4-10)
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Introduction
Acute coronary artery syndromes were urgent
events of coronary artery diseases, including unstable
angina, non-ST elevation myocardial infarction and ST
elevation myocardial infarction, the mortality was high,
early diagnosis and assessment of high-risk patients
were very important.
Doppler echocardiographic Tei index1 was an
index that could reflect both systolic and diastolic
function of myocardium, defined as the summation of
the isovolumic contraction and relaxation times divided
by ejection time. Myocardial ischemia could influence
both the systolic and diastolic function of the heart, so
it was reasonable for Tei index to assess acute coronary
artery syndromes.
B-Type natriuretic peptide (BNP) was cardiac
hormone secreted mainly from cardiac ventricles. It was
related to myocardial function, a lot of studies have
demonstrated its value in assessing heart failure patients,
recent studies had found that myocardial ischemia could
result in higher plasma BNP level too.2,3
The aims of this study were to elucidate: 1) The
value of Tei index and BNP in diagnosing high-risk
patients with acute coronary artery syndromes; 2) their
correlation with myocardial ischemia.

Materials and Methods

patients; (4) patients with renal, hepatic or thyroid
dysfunction; (5) patients with chronic pulmonary
hypertension and chronic obstruction pulmonary
disease; (6) obesity patients (BMI≥30 kg/m2). The study
was approved by regional scientific ethic committee.
All participants gave informed written consent.

Echocardiography
Echocardiography was performed by a single
investigator in the morning to exclude potential
influence of circadian variation. A Hewlett Packard
Sonos 5500 ultrasound instrument with a 3.5-MHz
transducer was used. Three cardiac cycles were stored
digitally. LV dimensions were measured as proposed
by the American Society of Echocardiography. LV
systolic function was estimated using ejection fraction
(EF) by Simpson's modified biplane method.6,7 Transmitral flow was recorded from the apical four-chamber
view with a 1-2 mm sample volume placed at the tips
of the mitral valve leaflets during diastole. Peak E
velocity (cm/s), peak A velocity (cm/s), E/A ratio,
deceleration time (DT) (ms) were obtained.8
Tei index was assessed from Doppler recordings
of LV inflow and outflow. From mitral inflow, the time
interval from cessation to onset of mitral inflow was
measured (A-interval). Ejection time (B-interval) was
measured from LV outflow velocity curve recorded from
an apical long-axis view. Tei index was calculated as
(A-B)/B (Figure 1).9

Study Population
The study population consisted of a consecutive
series of 83 patients (43 men and 40 women, mean age
60.2±9.8 years) with acute coronary artery syndromes
admitted to our hospital from February 2007 to February
2008, according to the direction of ACC/AHA,4,5 the
patients were divided into low-risk group and high-risk
group, 80 age- and gender-matched normal subjects
(42 men and 38 women, mean age 58.7±11.1 years)
who had undergone physical examination, X-ray,
echocardiography and electrocardiograph to excluded
primary or secondary heart disease were included as
controls. These patients were excluded from the present
study: (1) arrhythmia patients; (2) heart-pacemaker
transplanted patients; (3) serious valve heart disease
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ICT: isovolumic contraction time
IRT: isovolumic relaxation time
ET: ejection time

Figure 1. Tei index measurement.
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Reproducibility
Intraobserver variability was assessed in 10
patients by repeating the measurements on two
occasions (1 to 12 days apart) under the same basal
conditions. To test the interobserber variability, the
measurements were performed off-line from video
recordings by a second observer who was unaware of
the results of the first examination. Variability was
calculated as the mean percent error, derived as the
difference between the two sets of measurements,
divided by the mean of the observations.

32, respectively). For each principal vascular segment,
a multiplier was assigned based on the functional
significance of the myocardial area supplied by the
segment: left main coronary artery, × 5; Proximal
segment of the left anterior descending coronary artery
(LAD), × 2.5; proximal segment of the circumflex artery,
× 2.5; mid-segment of the LAD, × 1.5; right coronary
artery, distal segment of the LAD, posterolateral artery,
and obtuse marginal artery, × 1; and others, × 0.5.11

Statistic Analysis
Measurement of Plasma BNP Level
Venous blood sample for hormone analyses were
taken in the morning after 30 min of rest in supine
position. Blood was put into prechilled EDTA tubes.
Plasma was immediately separated by centrifugation
in 4 hours, BNP concentration was measured with the
commercially available AxSYM BNP assay. This fully
automated micro-particle enzyme immunoassay used
two monoclonal antibodies in a two-step format. Being
harmonized to the Biosite BNP assay, it had a dynamic
range of 0-4000 pg/ml. An evaluation including 70
consecutive patients with a clinical indication for BNP
measurement showed an excellent correlation between
the AxSYM BNP and the Biosite BNP assay at our
institution: AxSYM BNP=1.0104 × Biosite BNP+
0.2017.

Gensini Scores
Two cardiology doctors who were unaware of the
results of the level of plasma BNP and Tei index read
the coronary angiographic pictures, the number of
stenosis vessels and degree of coronary artery stenosis
were recorded, The degree of coronary artery stenosis
was evaluated by Gensini score system,10 which was a
measure of the extent and severity of coronary artery
disease and was computed by assigning a severity score
to each coronary segment according to the degree of
luminal narrowing and its geographic importance.
Reduction in the diameter of the lumen and the
roentgenographic appearance of concentric lesions, as
well as eccentric plaques, were evaluated (reductions
of 25, 50, 75, 90 and 99%, and complete occlusion
values were given Gensini scores of 1, 2, 4, 8, 16, and

6

Continuous variables were summarized as
mean±SD, the plasma BNP levels and Gensini score
were summarized as median and inter quartile range
(IQR). Comparisons between groups for continuous
variables were made using student's t-test. The KruskalWallis test was used to compare differences in BNP
levels and Gensini score between groups. Count data
was analyzed by X 2 test, correlations between
logGensini score and echocardiographic variables,
logBNP were analyzed using linear regression analysis.
To define the value of echocardiographic variables,
plasma BNP level to predict Gensini score, multivariate
stepwise regression analysis were conducted using
variables statistic significant in univariate analysis. A
probability value of <0.05 was considered significant.
All statistic analysis was performed by SPSS version
13.0.

Results
General Clinical Data
There were no difference as to age, sex, body
weight index between low-risk, high-risk patients with
acute coronary syndromes and the controls (p>0.05).
In high-risk group, more patients were involved in
multiple-vessel stenosis, the level of TnT were high,
blood pressure were low, heart dysfunction were worse
as assessed by NYHA class, the mortality during in
hospitals was high (p<0.05) (Table 1). Besides, there
were 25 diabetes patients, 6 patients with acute
pulmonary edema, 5 patients with heart shock, 9 patients
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with acute heart failure, 23 patients with TnT>20 ng/ml
in high-risk group.

Echocardiographic Analysis
Compared to the control group, Tei index were
much higher in low-risk and high-risk patients with
acute coronary artery syndromes (p<0.05), and there
was still difference between low-risk and high-risk
groups (p<0.05). EF which reflect the systolic
function of LV, was lower in high-risk group when
compared to the control group (p<0.05), However,
there was no difference between low-risk group and
the controls (p>0.05). Deceleration time (DT) was

shorter in high-risk group compared to control group
(p<0.05), while there was no difference between lowrisk group and the controls (p>0.05). In the control
group, E/A>1, in low-risk group, E/A<1, in high-risk
group, E/A>1, There were no statistic difference in
the three groups. Compared to the controls and the
low-risk group, LV dimensions were bigger in
high-risk group, while there were no difference
between the controls and low-risk group (p>0.05)
(Table 2).
Intraobserver variability for measurement of
the Tei index was 3.2±1.1%, interobserver variability
was 3.3±1.8%.

Table 1. General clinical data
Age
Sex (man/women)
BMI (kg/m2)
Systolic pressure (mmHg)
Diastolic pressure (mmHg)
TnT (ng/ml)
One-vessel stenosis
Two-vessel stenosis
Multiple-vessel stenosis
NYHA class
NYHA I
NYHA II
NYHA III
NYHA IV
Mortality
†

Control group

Low-risk group

High-risk group

58.7±11.1
42/38
24.6±2.3
128±14
75±11
0
0
0
0

61.8±10.1
22/21
25.1±3.1
124±8
76±9
5.2±2.4†
30
8
5

59.7±11.8
21/19
24.9±2.8
82±7†‡
56±12†‡
21.3±9.8†‡
2
10
28†‡

80
0
0
0
0

40
3
0
0
0

0
5
20
15
3

p<0.05 compared to the control group, ‡p<0.05 compared to low-risk group.

Table 2. Echocardiographic variables
LVESD (mm)
LVEDD (mm)
EF
E/A
DT (ms)
Tei
†

Control group

Low-risk group

29.4±4.2
49.3±5.9
75.1±6.8
1.24±0.26
191±35
0.32±0.06

29.7±9.5
54.2±4.0
69.4±11.7
0.86±0.33
186±38
0.48±0.09†

High-risk group
39.4±9.1†‡
62.1±8.2†‡
42.2±6.7†‡
1.16±0.57
142±45†‡
0.68±0.11†‡

p<0.05 compared to the control group, ‡p<0.05 compared to low-risk group.
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Plasma BNP Level
Compared to the control group, plasma BNP
levels were much higher in low-risk group and highrisk group (p<0.05), and the differences between lowrisk and high-risk groups was also significant (p<0.05)
(Table 3).

and age (p>0.05). Multiple stepwise regression analysis
showed that only Tei index and logBNP were
independent predictors of higher Gensini score
(r=0.52, p=0.01; r=0.32, p=0.01) (Table 4).

Discussion
Gensini Score
Compared to the control group, Gensini Score
were much higher in low-risk group and high-risk group
(p<0.05), and the differences between low-risk and highrisk groups was also significant (p<0.05) (Table 3).

Correlation between Gensini Score and
Echocardiographic Variables, Plasma BNP Level
There were significant correlation between
logGensini score and LV dimensions, EF, DT, E/A, Tei
index, logBNP, NYHA class, TnT level, the number of
coronary artery stenosis in liner regression analysis
(p<0.01), there were no correlation between logGensini

The present study found that Tei index, the plasma
BNP level were higher in patients with acute coronary
artery syndromes, the high-risk group had the highest
Tei index and plasma BNP concentration. Using Gensini
score system to evaluate myocardial ischemia, we found
that Tei index and BNP could independently predict
myocardial ischemia.

Tei Index
We found Tei index increased in patients with
acute coronary artery syndromes, maybe it was because
acute coronary artery syndromes could induce

Table 3. Plasma BNP level and Gensini score
Control group
BNP (pg/ml)
Gensini score
†

Low-risk group

29.2 (11.5-48.6)
0

94.5 (39.1-168.2)
10.8 (9.2-18.4)†

High-risk group
†

458.8 (183.8-1295.2)†‡
68.2 (46.5-101.2)†‡

p<0.05 compared to the control group, ‡p<0.05 compared to low-risk group.

Table 4. Correlation between Gensini score and Echocardiographic variables, plasma BNP level
Univariate

AGE
LVESD
LVEDD
EF
E/A
DT
NYHA class
TnT
Vessel stenosis
Tei
BNP
8

r
0.12
0.48
0.37
-0.58
0.29
-0.45
0.42
0.52
0.39
0.68
0.62

p
>0.05
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
April 2009

Multivariate
Standardized
regression coefficient
0.02
0.13
0.04
-0.12
0.10
-0.09
0.08
0.21
0.05
0.52
0.32

p
0.64
0.19
0.54
0.17
0.24
0.28
0.30
0.11
0.50
0.01
0.01

J HK Coll Cardiol, Vol 17

ZHANG ET AL.

myocardial ischemia, while myocardial ischemia
resulted in systolic or diastolic dysfunction of the heart,
so Tei index increased. Besides, Tei index was highest
in high-risk patients, properly because in high-risk
group, coronary artery stenosis index was high,
myocardial ischemia and myocardial dysfunction were
more serious, so Tei index increased significantly.
Further analysis found that EF decreased in low-risk
group and high-risk group, but there was no difference
between low-risk group and the controls, indicating that
systolic function of the herat had some reserve capacity,
only when myocardial ischemia reached to some extent,
EF decreased, maybe there was only diastolic
dysfunction in low-risk group patients, while in highrisk group, myocardial ischemia was more serious,
resulted to systolic dysfunction of the heart, so EF
decreased. One more question need to mention, E/A
decreased in low-risk group (<1), while increased
in high-risk group (>1), indicated the pseudonormalization phenomenon about E/A, and this was in
accordance with the past studies.12 So there were some
limitation using either EF or E/A to evaluating
myocardial function, Tei index could assess global
function of the heart more accurately and sensitively.

Plasma BNP Level
BNP was cardiac hormone that secreted mainly
from the cardiac ventricles in response to increased
pressure and volume, there were only a little BNP in
the circulation of healthy people, it kept the microcirculation stability of the heart, regulated the balance
of system blood and water and sodium.13
In the present study, we found that compared to
the control group, BNP was higher in patients with acute
coronary artery syndromes, this was in accordance with
past studies, 11,14 maybe because acute coronary
syndromes resulted in myocardial ischemia, while
ischemia contributed to transitorily or permanently
myocardial dysfunction, stimulated myocardium
synthesize and release BNP to the blood, and there were
nerve-hormone activation in patients with acute
coronary artery syndromes, contributed to the rise of
plasma BNP level. Plasma BNP level were highest in
high-risk patients, properly because myocardial
ischemia area was bigger in high-risk patients, so BNP

J HK Coll Cardiol, Vol 17

concentration increased. Suggesting BNP could
diagnose acute coronary artery syndromes, and it was
valuable in evaluating high-risk patients.
Actually, BNP could be affected by many
conditions, such as sex, age, heart rate, renal function,
and so on, besides, in one day, plasma BNP level could
be different at different time, medications could affect
plasma BNP level too, ACEI increased plasma BNP
level, while β-blockers decreased plasma BNP level.
In the present study, plasma BNP level were measured
in the morning, after 30 min of rest in supine position,
and no drugs were taken, so the factors affecting BNP
could be excluded.
In the present study, we used the universal
Gensini score to assess myocardial ischemia. Multiple
stepwise regression analysis showed only Tei index,
BNP were independent predictors of myocardial
ischemia, while LV dimensions, EF, DT, E/A had no
value. We proposed that 1) Ischemia could influence
both systolic and diastolic function of left ventricular,
not just systolic or diastolic function, so Tei index and
BNP as makers of "global cardiac function", could
reflect ischemia more accurately. 2) Ischemia may
stimulate the secretion of BNP, the more serious was
myocardial ischemia, and the higher was plasma BNP
concentration. Therefore, as indexes that could evaluate
both systolic and diastolic function of the heart, Tei
index and BNP could reflect myocardial ischemia
indirectly; they had some value in assessing high-risk
patients with acute coronary artery syndromes. Further
research found that, there was significant positive
correlation between Tei index and logBNP (r=0.75,
p=0.01). There was one more question need to mention,
past studies had proved that both Tei index and BNP
had positive correlation with NYHA class, in the present
study, most high risk patients were within NYHA class
III and IV, contributed to the higher Tei index and BNP,
these were in accordance with past studies, however,
we had proved NYHA class was not independent
predictors of myocardial ischemia.
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Conclusions
Tei index, plasma BNP concentration were higher
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in patients with acute coronary artery syndromes, and
they were highest in high-risk patients, they were
independent predictors of myocardial ischemia, had
some value in assessing high-risk patients with acute
coronary artery syndromes in clinical practice.
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